Drug Patents owned by Merz Pharms

1. List of Cuvposa drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7638552 MERZ PHARMS Method for increasing the bioavailability of glycopyrrolate
Aug, 2023

(4 months from now)

US7816396 MERZ PHARMS Method for increasing the bioavailability of glycopyrrolate
Aug, 2023

(4 months from now)

Drugs and Companies using GLYCOPYRROLATE ingredient

Market Authorisation Date: 28 July, 2010

Treatment: Reduce chronic severe drooling (i.e., sialorrhea) in patients with neurologic conditions associated with problem drooling

Dosage: SOLUTION;ORAL

How can I launch a generic of CUVPOSA before it's patent expiration?
More Information on Dosage

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic